Superworth

NU Skin Enterprises price to free cash flow NUS

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026
21.6×
10-year median
14.3×
Against its 10-year history
82nd
percentile: 0 is its lowest day, 100 its highest
10-year range
2.9× to 494×
Peer median
20.6×

NU Skin Enterprises' price to free cash flow is 21.6× as of Oct 23, 2026.

That is above its ten-year median of 14.3×, higher than on 82% of days in the last ten years.

Over that time it ranged from 2.9× in Oct 2024 to 494× in Oct 2023.

The median for 10 healthcare stocks of a similar size is 20.6×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far21.6×5.9×23.2×
20259.0×3.4×10.3×
20243.7×2.9×24.3×
202325.2×16.1×494×
202216.2×11.8×44.1×
202141.2×7.9×41.2×
202010.2×9.6×17.3×
201916.6×14.5×26.8×
201816.9×15.0×22.4×
201718.8×11.5×19.9×
201611.9×5.9×15.3×
20158.0×7.0×34.5×
201422.7×11.2×36.3×
201321.4×8.7×37.8×
20128.0×7.9×27.4×
201124.4×7.8×24.9×

Against its peers

Companies in Healthcare nearest NU Skin Enterprises' size, closest first, today.

CompanyPrice to free cash flow
NUSNU Skin Enterprises21.6×
UTMDUtah Medical Products20.6×
ELMDElectromed26.2×
NATRNatures Sunshine Products11.8×
PLXProtalix BioTherapeutics26.8×
PDEXPro DEX29.5×
INFUInfuSystem12.1×
VMDViemed Healthcare12.8×
EMBCEmbecta2.3×
ARVNArvinasn/m
NRCNRC Health22.4×
Peer median20.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on NU Skin Enterprises

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.